Research & Literature

Arrhythmogenic right ventricular cardiomyopathy. Contribution of cardiac magnetic resonance imaging to the diagnosis.

Perazzolo Marra M, Rizzo S, Bauce B, et al.

Herz 2015; (40(4)):600-6 doi:10.1007/s00059-015-4228-0.

Current Concepts on Diagnosis and Prognosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia.

Castaños Gutiérrez SL, Kamel IR, Zimmerman SL

Journal of thoracic imaging 2016; (31(6)):324-335 doi:10.1097/RTI.0000000000000171.

Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis.

Haugaa KH, Haland TF, Leren IS, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2016; (18(7)):965-72 doi:10.1093/europace/euv340.

Arrhythmogenic ventricular cardiomyopathy and sudden cardiac death: Left or right?

Rachoin R, Saleh BA, Mansour B, et al.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2017; (24(2)):527-533 doi:10.1007/s12350-016-0465-8.

[Redetection of tachycardia in severe ventricular undersensing].

Steffel J

Herzschrittmachertherapie & Elektrophysiologie 2016; (27(3)):240-3 doi:10.1007/s00399-016-0445-3.

Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes.

Akdis D, Brunckhorst C, Duru F, Saguner AM

Arrhythmia & electrophysiology review 2016; (5(2)):90-101 doi:10.15420/AER.2016.4.3.

Right ventricular arrhythmogenic cardiomyopathy: genetic and MR for modern clinical diagnosis.

Graziosi M, Rapezzi C

Journal of cardiovascular medicine (Hagerstown, Md.) 2017; (18 Suppl 1()):e157-e160 doi:10.2459/JCM.0000000000000470.

Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging.

Haugaa KH, Basso C, Badano LP, et al.

European heart journal. Cardiovascular Imaging 2017; (18(3)):237-253 doi:10.1093/ehjci/jew229.

Arrhythmogenic Right Ventricular Cardiomyopathy.

Corrado D, Link MS, Calkins H

The New England journal of medicine 2017; (376(15)):1489-90 doi:10.1056/NEJMc1701400.

Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).

Romero J, Grushko M, Briceño DF, et al.

Current cardiology reports 2017; (19(9)):82 doi:10.1007/s11886-017-0893-3.

Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients.

Denis A, Sacher F, Derval N, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2018; (20(FI1)):f30-f36 doi:10.1093/europace/euy007.

Desmosomes in Human Disease.

Najor NA

Annual review of pathology 2018; (13()):51-70 doi:10.1146/annurev-pathol-020117-044030.

Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.

El-Battrawy I, Zhao Z, Lan H, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2018; (20(FI1)):f46-f56 doi:10.1093/europace/euy042.

Subcutaneous Implantable Cardioverter-Defibrillator and Arrhythmogenic Right Ventricular Cardiomyopathy: The Importance of Repeat ECG Screening During Exercise Test.

Migliore F, Bertaglia E, Zorzi A, Corrado D

JACC. Clinical electrophysiology 2017; (3(7)):785-786 doi:10.1016/j.jacep.2016.10.014.

Myocardial inflammation detected by cardiac MRI in Arrhythmogenic right ventricular cardiomyopathy: A paediatric case series.

Martins D, Ovaert C, Khraiche D, et al.

International journal of cardiology 2018; (271()):81-86 doi:10.1016/j.ijcard.2018.05.116.

Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators.

Wang W, Cadrin-Tourigny J, Bhonsale A, et al.

Journal of cardiovascular electrophysiology 2018; (29(10)):1396-1402 doi:10.1111/jce.13668.

Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.

Wang W, Orgeron G, Tichnell C, et al.

Journal of the American Heart Association 2018; (7(12)) doi:10.1161/JAHA.118.008843.

[Genetic testing to prevent sudden cardiac death].

Stallmeyer B, Dittmann S, Schulze-Bahr E

Der Internist 2018; (59(8)):776-789 doi:10.1007/s00108-018-0462-x.

Arrhythmogenic Right Ventricular Cardiomyopathy: A Review of Living and Deceased Probands.

Blusztein DI, Zentner D, Thompson T, et al.

Heart, lung & circulation 2019; (28(7)):1034-1041 doi:10.1016/j.hlc.2018.07.017.

Cardiac magnetic resonance based deformation imaging: role of feature tracking in athletes with suspected arrhythmogenic right ventricular cardiomyopathy.

Czimbalmos C, Csecs I, Dohy Z, et al.

The international journal of cardiovascular imaging 2019; (35(3)):529-538 doi:10.1007/s10554-018-1478-y.

Arrhythmogenic Cardiomyopathy in 2018-2019: ARVC/ALVC or Both?

Bennett RG, Haqqani HM, Berruezo A, et al.

Heart, lung & circulation 2019; (28(1)):164-177 doi:10.1016/j.hlc.2018.10.013.

Prevalence and cardiac phenotype of patients with a phospholamban mutation.

Hof IE, van der Heijden JF, Kranias EG, et al.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2019; (27(2)):64-69 doi:10.1007/s12471-018-1211-4.

How ARVC-Related Mutations Destabilize Desmoplakin: An MD Study.

Daday C, Mateyka LM, Gräter F

Biophysical journal 2019; (116(5)):831-835 doi:10.1016/j.bpj.2019.01.023.

Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach.

Mathew S, Saguner AM, Schenker N, et al.

Journal of the American Heart Association 2019; (8(5)):e010365 doi:10.1161/JAHA.118.010365.

Comparison of CMR Findings according to the Presence or Absence of Isolated Focal Right Ventricular Dyskinetic Segments in Patients with Clinical Suspicion of ARVC.

Ko SM

Journal of cardiovascular imaging 2019; (27(2)):102-104 doi:10.4250/jcvi.2019.27.e24.

Sudden death related cardiomyopathies - Arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and exercise-induced cardiomyopathy.

Goff ZD, Calkins H

Progress in cardiovascular diseases 2019; (62(3)):217-226 doi:10.1016/j.pcad.2019.04.002.

Catheter ablation of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy.

Laredo M, Oliveira Da Silva L, Extramiana F, et al.

Heart rhythm 2020; (17(1)):41-48 doi:10.1016/j.hrthm.2019.06.022.

Disruption of Ca2+i Homeostasis and Connexin 43 Hemichannel Function in the Right Ventricle Precedes Overt Arrhythmogenic Cardiomyopathy in Plakophilin-2-Deficient Mice.

Kim JC, Pérez-Hernández M, Alvarado FJ, et al.

Circulation 2019; (140(12)):1015-1030 doi:10.1161/CIRCULATIONAHA.119.039710.

High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy.

Chivulescu M, Lie ØH, Popescu BA, et al.

European heart journal 2020; (41(14)):1401-1410 doi:10.1093/eurheartj/ehz570.

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary.

Towbin JA, McKenna WJ, Abrams DJ, et al.

Heart rhythm 2019; (16(11)):e373-e407 doi:10.1016/j.hrthm.2019.09.019.

Outcomes and management of arrhythmogenic right ventricular cardiomyopathy in pregnancy: a case report.

Schiavone M, Calcagnino M, Mazzanti A, Bonanomi C

European heart journal. Case reports 2019; (3(4)):1-5 doi:10.1093/ehjcr/ytz208.

Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5.

Dominguez F, Zorio E, Jimenez-Jaimez J, et al.

Heart rhythm 2020; (17(6)):945-954 doi:10.1016/j.hrthm.2020.01.035.

Exercise and arrhythmic risk in TMEM43 p.S358L arrhythmogenic right ventricular cardiomyopathy.

Paulin FL, Hodgkinson KA, MacLaughlan S, et al.

Heart rhythm 2020; (17(7)):1159-1166 doi:10.1016/j.hrthm.2020.02.028.

Arrhythmogenic cardiomyopathy: pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy.

van der Voorn SM, Te Riele ASJM, Basso C, et al.

Cardiovascular research 2020; (116(9)):1571-1584 doi:10.1093/cvr/cvaa084.

Arrhythmogenic Cardiomyopathy and Sports Activity.

Zorzi A, Cipriani A, Mattesi G, et al.

Journal of cardiovascular translational research 2020; (13(3)):274-283 doi:10.1007/s12265-020-09995-2.

Monozygotic twins with myocarditis and a novel likely pathogenic desmoplakin gene variant.

Kissopoulou A, Fernlund E, Holmgren C, et al.

ESC heart failure 2020; (7(3)):1210-1216 doi:10.1002/ehf2.12658.

Endo-epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.

Romero J, Patel K, Briceno D, et al.

Journal of cardiovascular electrophysiology 2020; (31(8)):2022-2031 doi:10.1111/jce.14593.

Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria.

Corrado D, Perazzolo Marra M, Zorzi A, et al.

International journal of cardiology 2020; (319()):106-114 doi:10.1016/j.ijcard.2020.06.005.

The Novel Desmin Variant p.Leu115Ile Is Associated With a Unique Form of Biventricular Arrhythmogenic Cardiomyopathy.

Protonotarios A, Brodehl A, Asimaki A, et al.

The Canadian journal of cardiology 2021; (37(6)):857-866 doi:10.1016/j.cjca.2020.11.017.

Arrhythmogenic Right Ventricular Cardiomyopathy Presenting as Clinical Myocarditis in Women.

Scheel PJ, Murray B, Tichnell C, et al.

The American journal of cardiology 2021; (145()):128-134 doi:10.1016/j.amjcard.2020.12.090.

Cardiomyopathies and Genetic Testing in Heart Failure: Role in Defining Phenotype-Targeted Approaches and Management.

Yogasundaram H, Alhumaid W, Dzwiniel T, et al.

The Canadian journal of cardiology 2021; (37(4)):547-559 doi:10.1016/j.cjca.2021.01.016.

Clinical Findings and Diagnostic Yield of Arrhythmogenic Cardiomyopathy Through Genomic Screening of Pathogenic or Likely Pathogenic Desmosome Gene Variants.

Carruth ED, Beer D, Alsaid A, et al.

Circulation. Genomic and precision medicine 2021; (14(2)):e003302 doi:10.1161/CIRCGEN.120.003302.

Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy.

Cappelletto C, Gregorio C, Barbati G, et al.

International journal of cardiology 2021; (334()):58-64 doi:10.1016/j.ijcard.2021.04.069.

The genetic architecture of Plakophilin 2 cardiomyopathy.

Dries AM, Kirillova A, Reuter CM, et al.

Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(10)):1961-1968 doi:10.1038/s41436-021-01233-7.

Arrhythmic risk stratification in arrhythmogenic cardiomyopathy: new predictors for left-sided variants?

Corrado D, Migliore F, Zorzi A

European heart journal 2021; (42(29)):2851-2853 doi:10.1093/eurheartj/ehab355.

Pathogenic variants in plakophilin-2 gene (PKP2) are associated with better survival in arrhythmogenic right ventricular cardiomyopathy.

Biernacka EK, Borowiec K, Franaszczyk M, et al.

Journal of applied genetics 2021; (62(4)):613-620 doi:10.1007/s13353-021-00647-y.

Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy.

Christensen AH, Platonov PG, Svensson A, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2022; (24(2)):306-312 doi:10.1093/europace/euab112.

Desmoplakin cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy: two distinct forms of cardiomyopathy?

Kukavica D, Trancuccio A, Arnò C, et al.

Minerva cardiology and angiology 2022; (70(2)):217-237 doi:10.23736/S2724-5683.21.05804-X.

Safety and efficacy of flecainide associated with beta-blockers in arrhythmogenic right ventricular cardiomyopathy.

Rolland T, Badenco N, Maupain C, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2022; (24(2)):278-284 doi:10.1093/europace/euab182.

Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy.

Corrado D, Zorzi A, Cipriani A, et al.

Journal of the American Heart Association 2021; (10(18)):e021987 doi:10.1161/JAHA.121.021987.

Epicardial differentiation drives fibro-fatty remodeling in arrhythmogenic cardiomyopathy.

Kohela A, van Kampen SJ, Moens T, et al.

Science translational medicine 2021; (13(612)):eabf2750 doi:10.1126/scitranslmed.abf2750.

Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants.

Gigli M, Stolfo D, Graw SL, et al.

Circulation 2021; (144(20)):1600-1611 doi:10.1161/CIRCULATIONAHA.121.053521.

Arrhythmogenic right ventricular cardiomyopathy: diverse substrate characteristics and ablation outcome.

Cheng WH, Chung FP, Lin YJ, et al.

Reviews in cardiovascular medicine 2021; (22(4)):1295-1309 doi:10.31083/j.rcm2204136.

Clinical and genetic features of arrhythmogenic cardiomyopathy: diagnosis, management and the heart failure perspective.

Castrichini M, Eldemire R, Groves DW, et al.

Progress in pediatric cardiology 2021; (63()) doi:10.1016/j.ppedcard.2021.101459.

Running the Risk: Exercise and Arrhythmogenic Cardiomyopathy.

Eberly L, Garg L, Vidula M, et al.

Current treatment options in cardiovascular medicine 2021; (23(10)) doi:10.1007/s11936-021-00943-0.

Predicting Sudden Cardiac Death in Genetic Heart Disease.

Cadrin-Tourigny J, Tadros R

The Canadian journal of cardiology 2022; (38(4)):479-490 doi:10.1016/j.cjca.2022.01.025.

The Keystones of Right Ventricular Arrhythmogenic Cardiomyopathy-Induced Morphological Disarrangement.

Avagimyan A, Kakturskiy L, Gogiashvili L, Aznauryan A

Current problems in cardiology 2022; (47(5)):101133 doi:10.1016/j.cpcardiol.2022.101133.

Structure and regulation of desmosomes in intercalated discs: Lessons from epithelia.

Yeruva S, Waschke J

Journal of anatomy 2023; (242(1)):81-90 doi:10.1111/joa.13634.

Myocarditis or inherited disease? - The multifaceted presentation of arrhythmogenic cardiomyopathy.

Westphal DS, Krafft H, Biller R, et al.

Gene 2022; (827()):146470 doi:10.1016/j.gene.2022.146470.

New Variant in Placophilin-2 Gene Causing Arrhythmogenic Myocardiopathy.

Caimi-Martinez F, Antoniutti G, Blanco R, et al.

Genes 2022; (13(5)) doi:10.3390/genes13050782.

Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.

Jordà P, Bosman LP, Gasperetti A, et al.

European heart journal 2022; (43(32)):3041-3052 doi:10.1093/eurheartj/ehac289.

What's New in Arrhythmogenic Cardiomyopathies.

Çimen T, Saguner AM

Journal of clinical medicine 2022; (11(16)) doi:10.3390/jcm11164764.

Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy.

Smedsrud MK, Chivulescu M, Forså MI, et al.

European heart journal 2022; (43(45)):4694-4703 doi:10.1093/eurheartj/ehac485.

[Arrhythmogenic right ventricular cardiomyopathy : An update].

Marchetti M, Pascale P, Muller O, Lu H

Annales de cardiologie et d'angeiologie 2022; (71(4)):223-227 doi:10.1016/j.ancard.2022.08.006.

Arrhythmogenic Right Ventricular Cardiomyopathy: The Role of Genetics in Diagnosis, Management, and Screening.

Odak M, Douedi S, Mararenko A, et al.

Cardiology research 2022; (13(4)):177-184 doi:10.14740/cr1373.

The Landscape of Cell Death Processes with Associated Immunogenic and Fibrogenic Effects in Arrhythmogenic Cardiomyopathy.

Lu W, Rao Y, Li Y, et al.

Journal of cardiovascular development and disease 2022; (9(9)) doi:10.3390/jcdd9090301.

Myocarditis-like Episodes in Patients with Arrhythmogenic Cardiomyopathy: A Systematic Review on the So-Called Hot-Phase of the Disease.

Bariani R, Rigato I, Cipriani A, et al.

Biomolecules 2022; (12(9)) doi:10.3390/biom12091324.

Biventricular Arrhythmogenic Cardiomyopathy Associated with a Novel Heterozygous Plakophilin-2 Early Truncating Variant.

Çimen T, Wilzeck VC, Montrasio G, et al.

Journal of clinical medicine 2022; (11(24)) doi:10.3390/jcm11247513.

DSP-Related Cardiomyopathy as a Distinct Clinical Entity? Emerging Evidence from an Italian Cohort.

Di Lorenzo F, Marchionni E, Ferradini V, et al.

International journal of molecular sciences 2023; (24(3)) doi:10.3390/ijms24032490.

Scarring/arrhythmogenic cardiomyopathy.

Corrado D, Zorzi A, Cipriani A, et al.

European heart journal supplements : journal of the European Society of Cardiology 2023; (25(Suppl C)):C144-C154 doi:10.1093/eurheartjsupp/suad017.

Endocardial-Epicardial Catheter Ablation Versus Endocardial Catheter Ablation Alone for Ventricular Arrhythmia in Patients With Structural Heart Disease (Meta-Analysis of Reconstructed Time-to-Event Data).

Shaheen N, Shaheen A, Elmasry M, Nashwan AJ

The American journal of cardiology 2023; (201()):185-192 doi:10.1016/j.amjcard.2023.05.068.

A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients.

Nagyova E, Hoorntje ET, Te Rijdt WP, et al.

Journal of cardiovascular translational research 2023; (16(6)):1276-1286 doi:10.1007/s12265-023-10403-8.

Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathy.

van Lint FHM, Hassanzada F, Verstraelen TE, et al.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2023; (31(7-8)):291-299 doi:10.1007/s12471-023-01800-4.

Recurrent Syncope in a Patient With Arrhythmogenic Right Ventricular Cardiomyopathy.

Castillo E

Cureus 2023; (15(9)):e45850 doi:10.7759/cureus.45850.

Recognizing a "Hot Phase" of An Arrhythmogenic Left Ventricular Cardiomyopathy: A Case Report.

Cabral M, Fernandes S, Ruivo C, et al.

Journal of the Saudi Heart Association 2023; (35(3)):232-234 doi:10.37616/2212-5043.1348.

Inflammation-A Possible Link between Myocarditis and Arrhythmogenic Cardiomyopathy.

Lala IR, Pop-Moldovan A

Diagnostics (Basel, Switzerland) 2024; (14(3)) doi:10.3390/diagnostics14030248.

Biventricular Arrhythmogenic Cardiomyopathy Mimicking Cardiac Sarcoidosis.

Kodali M, Galazka P, Ghafoor A, et al.

JACC. Case reports 2024; (29(4)):102198 doi:10.1016/j.jaccas.2023.102198.

Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic Cardiomyopathies.

Bariani R, Rigato I, Celeghin R, et al.

Journal of the American College of Cardiology 2024; (83(8)):797-807 doi:10.1016/j.jacc.2023.12.015.

Heterozygous desmoplakin (DSP) variants presenting with early onset cardiomyopathy and refractory ventricular tachycardia.

Mathavan A, Krekora U, Belaunzaran Dominguez M, Mathavan A

BMJ case reports 2024; (17(2)) doi:10.1136/bcr-2023-259308.

Case Illustration of the Natural History of Left Dominant Arrhythmogenic Cardiomyopathy.

Sanford CB, Fan J, Hua Y, et al.

Ochsner journal 2024; (24(1)):62-66 doi:10.31486/toj.23.0057.

Ventricular predominance in biventricular arrhythmogenic cardiomyopathy: Should new subtype criteria be recognized?

Luna-Alcala S, Garcia-Cardenas M, Guerra EC, et al.

Radiology case reports 2024; (19(6)):2457-2463 doi:10.1016/j.radcr.2024.03.014.

Results of comprehensive genetic testing in patients presenting to a multidisciplinary inherited heart disease clinic in India.

Chockalingam P, Geetha TS, Nair S, et al.

Indian heart journal 2024; (76(4)):260-267 doi:10.1016/j.ihj.2024.07.002.

New Diagnostic Approach to Arrhythmogenic Cardiomyopathy: The Padua Criteria.

Graziano F, Zorzi A, Cipriani A, et al.

Reviews in cardiovascular medicine 2022; (23(10)):335 doi:10.31083/j.rcm2310335.

Value of cardiac magnetic resonance feature-tracking in Arrhythmogenic Cardiomyopathy (ACM): A systematic review and meta-analysis.

MozafaryBazargany M, Salmanipour A, Ghaffari Jolfayi A, et al.

International journal of cardiology. Heart & vasculature 2024; (53()):101455 doi:10.1016/j.ijcha.2024.101455.

A right ventricular bulge: A clinical dilemma in diagnosis.

Allwood RP

Journal of clinical ultrasound : JCU 2025; (53(1)):213-217 doi:10.1002/jcu.23848.

The 2023 European Task Force Criteria for Diagnosis of Arrhythmogenic Cardiomyopathy: Historical Background and Review of Main Changes.

Graziano F, Zorzi A, Ungaro S, et al.

Reviews in cardiovascular medicine 2024; (25(9)):348 doi:10.31083/j.rcm2509348.

Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies.

Bassetto G, Angriman F, Gava CPLD, et al.

Current cardiology reports 2025; (27(1)):11.

Patient Preferences in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Screening and ICD Implantation: Canadian ARVC Registry Substudy.

Carroll SL, Pullman D, Gardner M, et al.

CJC open 2025; (7(1)):27-34 doi:10.1016/j.cjco.2024.10.007.

Diagnosis of Arrhythmogenic Cardiomyopathy in a Young Patient With Recurrent Myocarditis: The Importance of Genetic Testing.

Morales JP, Spaccavento A, Guerchicoff M, et al.

The American journal of cardiology 2025; (242()):37-40 doi:10.1016/j.amjcard.2025.01.034.

Rapid progression of right ventricular dysfunction: a case report.

Li G, Zhao C, Wu L, Yan Y

BMC cardiovascular disorders 2025; (25(1)):157 doi:10.1186/s12872-025-04601-2.

Desmoplakin Haploinsufficiency Underlies Cell-Cell Adhesion Failure in DSP Cardiomyopathy and is Rescued by Transcriptional Activation.

Smith ED, Jin K, Ferguson B, et al.

bioRxiv : the preprint server for biology 2025; doi:10.1101/2025.06.01.657304.

Desmoplakin cardiomyopathy: recent updates in natural history and management.

Hoffman-Andrews L, Anderson OG, Owens AT

Current opinion in cardiology 2025; (40(5)):375-380 doi:10.1097/HCO.0000000000001240.

Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive Individuals.

van der Heide MYC, Verstraelen TE, de Brouwer R, et al.

JACC. Heart failure 2025; (13(10)):102558 doi:10.1016/j.jchf.2025.102558.

Arrhythmogenic Cardiomyopathy or "Athlete's Heart"?: A Systematic Approach to Differential Diagnosis.

Minopoli TC, Kanthagnani K, Olivotto I, et al.

JACC. Clinical electrophysiology 2025; (11(11)):2532-2547 doi:10.1016/j.jacep.2025.08.026.

Clinical features and outcome of arrhythmogenic cardiomyopathy because of a desmoglein-2 founder variant: A multicenter study.

Fu B, Chen Z, Chen Z, et al.

Heart rhythm 2026; doi:10.1016/j.hrthm.2026.01.053.